Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation?

Cardiovascular Ultrasound

Volumn 12, Issue 1, 2014, Pages

  Faustino, Ana ^a   Providência, Rui ^a,b   Barra, Sérgio ^a   Paiva, Luís ^a   Trigo, Joana ^a   Botelho, Ana ^a   Costa, Marco ^a   Gonçalves, Lino ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; FLOW RATE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; LEFT ATRIUM APPENDAGE; MAJOR CLINICAL STUDY; MALE; NON VALVULAR ATRIAL FIBRILLATION; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ATRIAL FIBRILLATION; COMORBIDITY; COMPUTER ASSISTED DIAGNOSIS; ECHOGRAPHY; HEART ATRIUM; HEART VALVE DISEASES; INCIDENCE; PORTUGAL; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

AGED; ATRIAL FIBRILLATION; COMORBIDITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART VALVE DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENCE; MALE; PORTUGAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM;

EID: 84904521869     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-12-28     Document Type: Article

References (34)

1. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D, Circulation 1995 92 835 841
2. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Tsang T, Barnes M, Bailey K, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB, Mayo Clin Proc 2001 76 467 475
3. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR, Petty GW, Wiebers DO, Tsang TS, Mayo Clin Proc 2004 79 1008 1014
4. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB, J Am Coll Cardiol 2002 40 1636 1644
5. Risks for atrial fibrillation and congestive heart failure in patients ≥ 65 years of age with abnormal left ventricular diastolic relaxation. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB, Am J Cardiol 2004 93 54 58
6. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Aronow WS, Gutstein H, Hsieh FY, Am J Cardiol 1989 63 366 367
7. Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillation. Aronow WS, Ahn C, Kronzon I, Gutstein H, Am J Cardiol 1998 82 119 121
8. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD, Kopecky SL, Tsang TS, Seward JB, Eur Heart J 2005 26 2556 2561
9. Atrial size, atrial fibrillation and stroke. Caplan LR, D'Cruz I, Hier DB, Reddy H, Shah S, Ann Neurol 1986 19 158 161
10. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Vaziri SM, Larson MG, Benjamin EJ, Levy D, Circulation 1994 89 724 730
11. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Leung DY, Boyd A, Arnold H, Chi C, Thomas L, Am Heart J 2008 156 1056 1064
12. Prediction of cardiovascular outcomes with left atrial size. Is volume superior to area or diameter? Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB, J Am Coll Cardiol 2006 47 1018 1023
13. Comparison of echocardiographic single- vs biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography. Russo C, Hahn RT, Jin Z, Homma S, Sacco RL, Di Tullio MR, J Am Soc Echocardiogr 2010 23 9 954 960
14. Left atrial size: physiologic determinants and clinical applications. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, Tsang TSM, J Am Coll Cardiol 2006 47 2357 2363
15. How many patients would be misclassified using M-mode and two-dimensional estimates of left atrial size instead of left atrial volume? A three-dimensional echocardiographic study. Badano LP, Pezzutto N, Marinigh R, Cinello M, Nucifora G, Pavoni D, Gianfagna P, Fioretti PM, J Cardiovasc Med 9 476 484
16. What is the best approach for the assessment of left atrial size? Comparison of various unidimensional and Two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume. Maddukuri PV, Vieira ML, DeCastro S, Maron MS, Kuvin JT, Patel AR, Pandian NG, J Am Soc Echocardiogr 2006 19 1026 1032
17. How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods. Khankirawatana B, Khankirawatana S, Porter T, Am Heart J 2004 147 369 374
18. Atrial volume in a normal adult population by two-dimensional echocardiography. Wang Y, Gutman JM, Heilbron D, Wahr D, Schiller NB, Chest 1984 86 595 601
19. Recommendations for chamber quantification. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, Sutton MSJ, Stewart W, Eur J Echocardiogr 2006 7 79 108
20. Stroke Prevention in Atrial Fibrillation III Investigators. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG, J Am Coll Cardiol 1998 31 1622 1626
21. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF, J Am Coll Cardiol 1994 24 755 762
22. Antithrombotic therapy in atrial fibrillation. The Sixth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE, Chest 2001 119 194S 206S
23. Additive role of plasma von Willebrand Factor levels to clinical factors for risk stratification in patients with atrial fibrillation. Lip GYH, Lane D, van Walraven C, Hart RG, Stroke 2006 37 2294 2300
24. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography, Ann Intern Med 1998 128 639 647
25. The role of echocardiography in thromboembolic risk assessment of patients with nonvalvular atrial fibrillation. Providência R, Trigo J, Paiva L, Barra S, J Am Soc Echocardiogr 2013 26 801 812
26. Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ, JAMA 2001 285 2864 2870
27. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, Chest 2010 137 263 272
28. Clinical features of intracardiac thrombosis based on echocardiographic observation. Beppu S, Park YD, Sakakibara H, Nagata S, Nimura Y, Jpn Cite J 1984 48 75 82
29. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. Beppu S, Nimura Y, Sakakihara H, Nagata S, Park YD, Izumi S, J Am Coll Cardiol 1985 6 744 749
30. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. Fatkin D, Kelly RP, Feneley MP, J Am Coll Cardiol 1994 23 961 969
31. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Gelder ICV, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, Eur Heart J 2010 31 2369 2429
32. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Wann LS, Curtis AB, Ellenbogen KA, Estes M, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Circulation 2011 123 1144 1150
33. Echocardiographic predictors of left atrial appendage thrombus formation. Ayirala S, Kumar S, O'Sullivan DM, Silverman DI, J Am Soc Echocardiogr 2011 24 499 505
34. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Providência R, Botelho A, Trigo J, Quintal N, Nascimento J, Mota P, Leitão-Marques A, Europace 2012 14 36 45